ARCHIVES

ASC Survey Leads to Strategic Plan Development, Office In Washington

This article is from The Cancer Letter archive.

Vol. 15 No. 23 | June 9, 1989

Download PDF Visit The Full Archive

Related Articles

FDA Continues Bureaucratic Delays Of Cancer INDs

January 30, 1976

IOM Report Calls For FDA Authority Nutritional Supplement Health Claims

May 21, 2010

In Brief: NCI Will Stop Free Group C distribution Of VP-16 Sept. 1 Unless Bristol Supplies It At No Charge

June 25, 1982

NCI Director Says Research Budget Cuts Result in Untold “Missed Opportunities,” Provides List of Program Reductions.

March 9, 2007

In Breif: FDA Issues Uterine Cancer-Tamoxifin Warning; Fisher Declined Invitation To Speak At AACR

April 15, 1994

Includes 8-page April 2002 Business & Regulatory Report.

May 3, 2002